openPR Logo
Press release

Biochips Market Extremely Effective & Produce Accurate Gene Sequencing Results

03-02-2017 11:18 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Biochips Market Extremely Effective & Produce Accurate Gene

This market research study analyzes the biochips market on global basis and provides estimates in terms of revenue (USD million) from 2014 to 2023.

It describes the market dynamics affecting the industry and analyzes their impact through the forecast period. Moreover, it highlights the significant opportunities for market growth in the next eight years.

Biochips are a collection of microarrays which are arranged on a solid substrate that enables numerous biochemical reactions such as decoding of genes in a few seconds.

In addition, biochips are designed to function in biological environments and are capable of detecting and measuring a large number of biomarkers and perform complex biochemical reactions simultaneously in a very short span of time.

There have been considerable advancements in the biotechnology industry on account of the increasing application of biochips. In addition, biochips are largely used for research in drug discovery and development, genomics, proteomics, and molecular diagnostics.

Make an Enquiry:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10151

Biochips help in analyzing organic molecules related to living organisms. Therefore, they help in detecting gene sequences, environmental pollutants, airborne toxins, and other biochemical constituents.

Increasing application of biochips in the medical sector for cancer treatment, drug research, and diagnostics is one of the major factors driving the growth of the global biochips market.

In addition, factors such as availability of molecular information, automation of biochemical processes through the use of biochips and application of biochips for gene and protein identification are set to drive the global biochips market.

Significant growth in the healthcare sector, rising demands for diagnostics and increasing medical expenditure coupled with economic reforms in major developing countries has been able to bolster the growth of this market. Asia Pacific and Rest of the World (RoW) are key markets for the future and are expected to provide huge opportunities to the global biochips manufacturers.

About TMR

TMR is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact TMR

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:sales@transparencymarketresearch.com
Website:http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biochips Market Extremely Effective & Produce Accurate Gene Sequencing Results here

News-ID: 455552 • Views: 340

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Biochips

Biochips Market: Crucial Role of Biochips in Drug Discovery and Development
The vendor landscape of the global biochips market is extremely fragmented, speckled with a number of small, medium, and large enterprises. Considering that it is not a monopolistic scenario, the entry of new players is not restricted, giving vendors immense scope. In view of this, Transparency Market Research finds that despite being the leading players in the biochips market, Affymetrix Inc., Agilent Technologies Inc., and Illumina Inc. together accounted for
Global Biochips Market: mainly propelled by rising applications of biochips
SAN FRANCISCO, May. 02, 2018 According to the latest report published by Variant Market Research, the global biochips market size is projected to reach $22 billion by 2024 from $6 billion in 2016. In this report, global biochips market forecast says that the global market is growing at 15.5% CAGR from 2016 to 2024. On the basis of geography, Asia Pacific is expected to grow at a CAGR of 16.7%
Biochips Market - Crucial Role of Biochips in Drug Discovery and Development
The vendor landscape of the global biochips market is extremely fragmented, speckled with a number of small, medium, and large enterprises. Considering that it is not a monopolistic scenario, the entry of new players is not restricted, giving vendors immense scope. In view of this, Transparency Market Research finds that despite being the leading players in the biochips market, Affymetrix Inc., Agilent Technologies Inc., and Illumina Inc. together accounted for
Biochips Market: Immense Scope for New Entrants and Innovative Applications Make …
The vendor landscape of the global biochips market is extremely fragmented, speckled with a number of small, medium, and large enterprises. Considering that it is not a monopolistic scenario, the entry of new players is not restricted, giving vendors immense scope. In view of this, Transparency Market Research finds that despite being the leading players in the biochips market, Affymetrix Inc., Agilent Technologies Inc., and Illumina Inc. together accounted for
Biochips Market Report
According to the new market research report, “Biochips Market, by Types (Protein Chips, DNA Chips, Lab-on-a-chip), Fabrication Technologies (Microarrays, Microfluidics), Applications (Drug Discoveries, Gene Expression, Genomics, In-vitro Diagnostics, Proteomics) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022”, published by Scalar Market Research, the global biochips market is expected to grow at a healthy rate during the forecast period. The global biochips market report offers in-depth analysis of the
Biochips Market Rises due to Rising Investments in Development of Biochips Techn …
Biochips are a collection of microarrays or micro-test sites fixed on a solid substrate to perform multiple tests at the same time for achieving enhanced speed and throughput. They are small, wafer-like components that are made from substrates such as soda glass, fused quartz, silicon, and plastic. Biochips are effectively a miniature laboratory that functions to perform several biochemical reactions simultaneously. INFORMATION OF BIOCHIPS MARKET WORLDWIDE: http://www.transparencymarketresearch.com/biochips-market.html The positive growth rate in the